chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had nausea, vomiting, and loss of appetite starting later in the eveing on the day she received her second COVID vaccine. Told patient they needed to reach out to their primary care physician or go to the ED to see if they could get a nausea medication
Can no longer take ibuprofein - If i take it - it makes my left eye swell up.  I've noticed that it is for all anti inflammatory as well.  I can't take my allergy eye drops either as that will make my left eye swell up.  Swelling last a couple days.  Swelling happens within an hour.  I got dark spots on my hands.  Looks like aging spots.  They lasted a couple months and then they dissapeared.  I have developed a cough 1.5 months ago and it has not gone away.  I also get shortness of breath when i talk to others.  Crazy thing is that i can run 10+ miles or ride a bike 50+ miles and it hasn't slowed me down.  It did initial but i'm working through it where it doesn't bother me much now.
pt recv vax 28NOV97 & pt exp a large local rxn of 5cm x 5cm w/swelling, redness & induration on the back of arm;also exp SOB:
Chills, severe pain in arm the vaccine shot was given, intense fatigue the following two days enough to be completely immobilized.  Muscle pain and fatigue that come and go even after two weeks
Developed rash between Friday and Saturday. Raised red itch, 5 - 7 spots on neck, arm and leg, sores inside of mouth. Parent took child to ER - no family doctor - diagnosed by ER physician with varicella disease.
Generalized erythematous rash over upper half of body & extremities. Later over lower extremities also. Abdominal pain on 7th day. Symptoms x 8 days. BENADRYL & Prednisolone & Ranitidine given.
Patient states shortly after he received the vaccine, he developed intermittent bilateral upper and extremity numbness/tingling x 2 weeks. CTA/CTV head ruled out cerebral venous sinus thrombosis. MRI cervical, thoracic, and lumbar spines showed degenerative disk disease.
Low grade fever from 11pm 9/19 to approx 1am 9/22, chills, body ache, flank pain with normal urine output and coloration, muscle ache, joint pain intermittent, headache, exhaustion, soreness at injection site preventing use of arm, tingling in right fingertips at thumb, point, and half of middle finger at upper digit ventral side, on 9/22 development of blotchy flat rash above injection site first observed approx 2pm. On 9/23 pain at injection site was mild, mild headache and body ache, no fever, pins-needles sensation on tops of feet, and rash on left shoulder (blotchy flat pinkish and warm to touch versus non-reddened areas.)
I had abdominal pain after being pregnant. Hospital - April 15 -  ER for the pain and they found a hemorrhage between uterus and placenta.
A spontaneous non-serious report of scabies was received from a nurse concerning a nine year old male patient subsequent to FLUMIST. Medical history and concomitant medications were not reported. On 18-Nov-2008 the patient received FLUMIST. On 27-Nov-2008, nine days after receiving FLUMIST, the mother took the patient and his sister, who also receive FLUMIST, to the emergency room (ER) with rash on their arms and body that started on or shortly after the day the patient received FLUMIST. Treatment included BENADRYL and acyclovir. The attending physician in the ER diagnosed the patient with scabies and not an allergic reaction. At the time of the report, the event of scabies was ongoing and may be worsening.
Information has been received from a medical assistant concerning a 41 year old female patient with multiple sclerosis and no known drug allergies who on 09-OCT-2009 was vaccinated with a first dose of PNEUMOVAX 23. Concomitant therapy included FIORICET. It was reported that on 09-OCT-2009 the patient developed an erythematous area at the site of injection after administration of PNEUMOVAX 23. On the same day the area now extended down her arm and had blisters (almost zoster-like rash). She also had a cough. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered. This is one of two reports received from the same source. Additional information has been requested.
It started off two weeks after vaccination I woke up with an earache, sore throat and the next day body aches and start of congestion a day later diarrhea.
Received KINRIX and PROQUAD in left thigh on 4-14-17. By 7:30 that evening had redness where vaccines were administered. Saturday 4-15-17 patient still had redness and thigh was painful. Sunday 4-16-17 there was a 6 inch wide red, hot, swollen painful area. Had knee pain (L) and left toes felt "funny". Went to urgent care - said it was vaccine reaction. Instructed to do BENADRYL and ibuprofen.
Initial information received on 13-Aug-2018 regarding an unsolicited valid non-serious case received from a consumer/non-HCP. This case involves a 11 years old male patient who experienced arm pain from the injection, tiredness, headache and optic nerve was elevated, while he received vaccines HPV VACCINE, TDAP and MENACTRA. The patient's past medical history included Headache. The patient's past medical treatment(s), vaccination(s) and family history were not provided. On 02-Aug-2018, the patient received a first dose of suspect MENACTRA lot number not reported via unknown route. On 02-Aug-2018, the patient received a dose of suspect TDAP not produced by Sanofi Pasteur lot number not reported via unknown route. On 02-Aug-2018, the patient received a dose of suspect HPV VACCINE not produced by Sanofi Pasteur lot number not reported. The patient developed a non-serious arm pain from the injection following the administration of MENACTRA, following the administration of TDAP and following the administration of HPV VACCINE. The patient developed a non-serious tiredness following the administration of MENACTRA, following the administration of TDAP and following the administration of HPV VACCINE. The patient developed a non-serious headache following the administration of MENACTRA, following the administration of TDAP and following the administration of HPV VACCINE. The patient developed a non-serious optic nerve was elevated (optic nerve disorder) following the administration of MENACTRA, following the administration of TDAP and following the administration of HPV VACCINE. (Other relevant tests included No lab test.) Final diagnosis was optic nerve was elevated, headache, tiredness and arm pain from the injection. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for arm pain from the injection, as Unknown for tiredness, as Unknown for headache and as Unknown for optic nerve was elevated.
Pt received INFLUENZA A H1N1 shot at 14:20. At 14:40 pt c/o tightness in chest, pt was wheezing also. Her B/P was 146/80, P-108, R-16. Pt took 2 puffs of her ALBUTEROL inhaler at this time. At 14:50 her symptoms had resolved. B/P 120/70, P 80, R 16.
Within a few hours, vaccine recipient presented with acute diarrhea and gastrointestinal upset.  Gastrointestinal system remained unsettled for 3 days post vaccination.
Vomiting; joint pain; fever; constant right intercostal pain; lack of energy; headache; intestinal flatulence; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 56-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number: Er8737, expiry date: not reported ), via an unspecified route of administration, administered in Arm Right on 12Apr2021 18:00 (at the age of 56-years old) as dose 1, single for covid-19 immunisation. Medical history included COVID-19 (covid prior vaccination: Yes). The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. On 04May2021 05:00, the patient experienced vomiting, joint pain, fever, constant right intercostal pain, lack of energy, headache, intestinal flatulence. All these symptoms persist after one week of vaccination ( as reported) .The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
screaming episode could'nt be comforted 1030PM of day recvd vax; call MD-no visit made; better w/in 24 hrs
Excruciating pain from my left arm into my left side all the way down my left leg, shouting intense pain from the inside grown in to the knee of the left leg. Was unable to stand or walk due to severe pain.
No additional AEs or PQC reported; PROQUAD was administered after temperature excursion; This spontaneous report as received from a medical assistant refers to a 4 year old male patient with no illness at time of vaccination or pertinent medical history.  The patient had 2 siblings. On 02-JAN-2023, the patient was vaccinated with the second improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) rHA (lot # W026316 exp date 18-FEB-2024) (dose not reported) subcutaneously in the right arm at a private hospital. The medical assistant reported that the freezer door was left ajar.  This is one of several reports received from the same source. .
Redness, warmth, tenderness at injection site persisting. Initial low grade temp and myalgia which resolved after 24 hours.
loss of voice; hoarseness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of APHONIA (loss of voice) and DYSPHONIA (hoarseness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APHONIA (loss of voice) and DYSPHONIA (hoarseness). At the time of the report, APHONIA (loss of voice) and DYSPHONIA (hoarseness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant drugs were reported.  No Treatment medications were reported.   Reporter did not allow further contact
urine was bright orange; This spontaneous case was reported by a pharmacist and describes the occurrence of CHROMATURIA (urine was bright orange) in a 30-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. as7163b) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer COVID19 vaccine (1st booster) on 09-Mar-2021, COVID-19 vaccine (1st dose.) and COVID-19 vaccine (2nd dose.). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, COVID-19 vaccine and Pfizer COVID19 vaccine.    On 27-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHROMATURIA (urine was bright orange). At the time of the report, CHROMATURIA (urine was bright orange) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Mom reported temp of 102.5  & next day 12MAR92; t16.1 adm to hosp where t102.1;
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. No known allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 26Sep2023 to 01Oct2023. Clinical course: the patient received COVID-19 Vaccine (Pfizer/Biontech brand) on "15Aug2020" (as reported).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300324048 same patient, different vaccine/event;
Large knot under skin.  Swelling, redness, soreness,  area surrounding injection site is hot.
Initial information received on 12-Jul-2018 regarding an unsolicited valid non-serious case received from a other health professional. This two month old patient who was vaccinated with an expired dose of PENTACEL (batch number, expiry date 24-JUN-2018, route and site of administration were not reported) on 11 July 2018. It was a case of actual medication error due to expired vaccine used. It was unknown if any adverse event was occurred. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
the day following vax pt exp arm swelling/pain, entire lt upper arm red, warm, tender w/vesicular papules. resolved within 5days w/ice & motrin
p/vax pt felt extremely fatigued, short of breath, could hardly stay awake even p/lots of sleep, also felt weak.
Patient's caregiver called to express concern about the site of ZOSTAVAX injection. Specifically, per caregiver, the injection site is still pink but fading since November 1, 2012. Patient is contacted and confirmed, she is fine. Patient experienced soreness at the time of receiving the shot. Patient currently experiences neither pain nor any other side (adverse) effects even though the light pink discoloration is still presented. This STARS event is written up per Immunization Department's suggestion. This report is not a result of patient's complaint. Patient has an appointment to see her PCP about a separate issue. Per patient, she will ask MD about this skin discoloration and will let us know. Therefore, she does not want us to contact MD directly.
Significant swelling of left arm with erythema spreading 10 x 8 cm, hot to touch, transient pain.
swelling rt ax region & later swelling & redness rt deltoid area @ site of inject;
CHILLS, FEVER UP TO 105.5, FATIGUE, ANOREXIA,
Information has been received from a physician concerning an elementary school age female who was vaccinated with a single dose of Varivax. The physician reported that the patient subsequently developed a moderate case of chickenpox. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Pt fainted at check out desk about 1 minute after receiving vaccine, was passed out for about 15 seconds. Pt was brought back to room, feet elevated, and evaluated by MD.
I felt crummy all day. I had a fever of 101.7 Stayed in bed all day. I wound up having a seizure, and going to the emergency room at the hospital. I had EKG, blood work done and fluid.
contracted covid 19 infection 2 days after their first dose; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection), via an unspecified route of administration on an unspecified date (at the time of 78-years-old) at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date it was reported that patient and her husband (both 78 years old) were due for their second doses of Pfizer-Biontech Covid19 vaccine this Saturday, which is 3 weeks after their first dose. Caller reports that they contracted covid -19 infection 2 days after their first dose, and their HCP (healthcare professional) suggested they go ahead and receive their second dose as scheduled, but she wanted to check with Pfizer as well. Outcome of the event was unknown.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Patient became light headed and fainted from a seated position about 10 minutes after her first Pfizer COVID-19 vaccination. She doesn't think she lost consciousness. Her skin was quite warm and sweaty after this event. I had her remain laying down on the ground while she recovered and I assessed her symptoms. She felt better almost immediately so I had her move to the pharmacy office for observation for an additional 15-20 minutes. She then reported that she has fainted with shots before and she hadn't eaten anything today. Her mother said this has happened before and drove her home once she felt well again.
When it was time to mix the diluent with the pfizer vaccine, I was reading through the instructions and I had girl 1 draw up the diluent. She drew up the correct amount of 1.8 ml and I checked it. As she was putting the diluent into the pfizer vaccine, a very small amount of the diluent spilled from the syringe and at the top of the needle. She put in the rest of the diluent and then we took the rest of what was left of the diluent and put it inside the the vaccine. When it was all mixed, it looked like we would have the correct amount. We withdrew 1 dose at a time with the correct amount. When we withdrew the the 4th dose, there was only a little bit left on the vial but not enough to give the 5th dose. I really thought there would be enough for 6 doses since we took the rest of the diluent that was left over and put it inside the vial which was 0.2 ml. I should of stopped what I was doing and called someone for help. I will take this as a learning lesson and will be more diligent in the future.
This patient is not a vacinee, but rather a contact with potential exposure to smallpox vaccine recipient. The patient presented today to clinic complaining about an arm skin lesion that had worsened since or around the time he visited his nephew, who had been vaccinated prior to his visit. The patient is known to be HIV positive, CD4 count of 160 VL <400. Apparently he had a skin lesion on his arm, present for about 2 weeks that "in the past week" had become pustular and ulcerated. It is currently about 6 mm, pustular ulcerated and has 1 cm surrounding erythema. He visited his nephew 5 days ago. In addition, the physician noted 3 facial lesions on the face (1 on the cheek, two near the chin sizes ranging from 2 to 5 mm) one was vesiculated "with cloudy fluid", one was crusted and the other papular. The patient claims that he had "something" on his face but these were not "of any concern" and since or around the time of the visit to his nephew have progressed to the current presentation. The patient was not toxic, but the physician was concerned about cellulitis on the arm and is going to treat it as such  He does not recall a history of chicken pox or recent exposure to it. He does not have a history of HIV related skin problems or other chronic skin problems. He has a vaccinia scar, but date of prior vaccination is not known. Dr. unroofed a lesion but was not able to get the "roof", but he got a skin bx and 4 touch preps. I spoke to MD's about running the vaccinia diagnostic tests and they are not going to be able to do this so I contacted another MD, and if she gets the specimen today she will set it up overnight and have a result by tomorrow afternoon. In addition, the patient will have DFA testing for varicella and herpes through this clinic. The patient is going to be treated with Diclox and the dose of Valtrex will be increased to active treatment dose. Dr.'s impression is that t On a follow up report received 6/6/2003 it is added: Dr's impression is that the pt has furuncullosis vs vaccinia acquired through contact with vaccinee. Tzanck, DFA and PCR testing are all negative. The final diagnosis remains Furuncullosis.
When I woke up the next morning after my second does of Moderna, I got my period.  I haven?t gotten it in two years due to menopause.  Very odd that I got it after so long, and the day after my vaccine.  Just more FYI for your public records.
Major behavior changes - Out of control behavior, crying, screaming, inconsolable, eventually falling asleep. Next day continued behavior changes, out of control, crying, screaming, freaking out, inconsolable for over an hour, general loss of control, could not be calmed down by anyone, had look of fear in eyes like he couldn't stop himself.
Dose 2 for Pfizer ages 6 months to <5 years was given in the form of Pfizer Bivalent versus Pfizer Monovalent as recommended
tinny, metallic taste and feeling in mouth, consistent for entire week following vaccine and fatigue in evening.
Pt in hospital until 1 week prior. Complain of total body myalgias and HA which worsened throughout week till arrival at ER with acute  2/19/09-records received for DOS 5/2/08. DC Thrombolic thrombocytopenic purpura. Plasmapheresis. Presented with altered mental stastus, fevers, myalgias and headche. One week ago C/O myalgias, fatigue and nonspecific diffuse muscle weakness and constant headache progressively worsened. Possible tactile fevers, arm numbness. Mild cough, congestion, rhinorrhea attributed to season allergies. New onset of bruising. Vomited in ED, disoriented and incoherent.
This spontaneous report was received from a consumer via her husband and was published in a newspaper article. Obtained information refers to a 18 year old male patient (reporter's son). No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On an unknown date, the patient was vaccinated with M-M-R II injection (dose, route of administration, lot # and expiration date were not reported). The reporter stated that her son changed overnight after having a jab and became autistic (dates unspecified). The outcome of the adverse event was not reported. The reporter claimed a connection between the adverse event and M-M-R II. Additional information is not expected as no contact details were provided.
Received Pfizer vaccine #1 on 01/22/21 and seven days after developed severe vertigo and vomiting.  Received Pfizer vaccine #2 on 2/12/21 and 3 days later developed severe Vertigo and Vomiting.